Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease (CogCheck-MC)
Sponsor: University Hospital, Basel, Switzerland
This observational or N/A phase trial investigates Cognition Disorders and Dementia Alzheimers and is currently actively recruiting participants. University Hospital, Basel, Switzerland leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Dec 2022 — Apr 2024 [monthly]
Recruiting
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Oct 2019 — Dec 2020 [monthly]
Not Yet Recruiting
-
Oct 2018 — Oct 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .